Gastroenterology

Dr. Evan Dellon said up to 8 biopsies for high risk patients could be beneficial in diagnosing different diseases impacting the esophagus.

Sucrase isomaltase deficiency is often overlooked symptom in adult patients with IBS-D.

COVID-19 patients with liver injuries are at a higher risk of mortality or lengthier hospital stays.

Data show nearly 1 in 10 patients with IBS-D in study were identified with SID.

Data show adverse events occurred in 6.67% in the cohort of patients with IBD.

Most of the data on vedolizumab has been limited by small sample sizes and short follow-up.

About a quarter of Cologuard's ordered by patients are deemed to be inappropriate.

Infections in patients with ulcerative colitis treated with ozanimod were mostly characterized as non-serious.

The treatment would represent the first microbiota-based live biotherapeutic to show efficacy in the first recurrence of CDI.

Data show adverse outcomes include increased mortality rates, prolonged hospital stay, and higher hospitalization chargers.

Data show global burden of NAFLD increased, while burden of cirrhosis decreased in adolescents and young adults.

Ulcerative colitis patients with fatigue are more likely to be unemployed, have moderate or severe disease, and higher Mayo scores.

Data show males, patients with high BMI correlated with higher FAST score in HCV care.

Data show clinically meaningful improvement in IBDQ score and MCS score in patients treated with UST.

Data show a 23.5% increase in influenza vaccination rates.

Data show biologic therapy was not associated with ICU admission or death due to infection.

C difficile and sepsis infections can be especially difficult to treat.

SER-109 resulted in a 73% reduction in relative risk for CDI over 8 weeks.

Hospitalizations were more likely in patients with CDI of small bowel and Crohn's disease, with worse outcomes noted in patients admitted to ICU.

There is a substantial health care cost for CDI patients with sepsis.

In data presented at DDW, researchers find a decrease in hospital-acquired CDI infections in 2020 when compared to 2018 and 2019.

The researchers developed a computerized clinical decision support tool to help clinicians prescribe probiotics.

A large proportion of HCV patients remain undiagnosed, particularly in the older population.

Vonoprazan has shown more potent acid inhibitory effects than PPI.

An electronic reminding system helped identify 3783 patients with anti-HCV antibody documentation.